Mechanism-based
inactivation (MBI) refers to the metabolic bioactivation
of a xenobiotic by cytochrome P450s to a highly reactive intermediate
which subsequently binds to the enzyme and leads to the quasi-irreversible
or irreversible inhibition. Xenobiotics, mainly drugs with specific
functional units, are the major sources of MBI. Two possible consequences
of MBI by medicinal compounds are drug–drug interaction and
severe toxicity that are observed and highlighted by clinical experiments.
Today almost all of these latent functional groups (e.g., thiophene,
furan, alkylamines, etc.) are known, and their features and mechanisms
of action, owing to the vast experimental and theoretical studies,
are determined. In the past decade, molecular modeling techniques,
mostly density functional theory, have revealed the most feasible
mechanism that a drug undergoes by P450 enzymes to generate a highly
reactive intermediate. In this review, we provide a comprehensive
and detailed picture of computational advances toward the elucidation
of the activation mechanisms of various known groups with MBI activity.
To this aim, we briefly describe the computational concepts to carry
out and analyze the mechanistic investigations, and then, we summarize
the studies on compounds with known inhibition activity including
thiophene, furan, alkylamines, terminal acetylene, etc. This study
can be reference literature for both theoretical and experimental
(bio)chemists in several different fields including rational drug
design, the process of toxicity prevention, and the discovery of novel
inhibitors and catalysts.